• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Rapid transitions in cause-specific mortality in China from 1990-2013

byMelissa McCoyandXiaozhou Liu
October 27, 2015
in Chronic Disease, Public Health
Reading Time: 3 mins read
Standardized central line care practices reduce bloodstream infections
Share on FacebookShare on Twitter

1. The leading causes of years of life lost (YLL) changed dramatically between 1990 and 2013. 16 of 33 provinces had lower respiratory infections or preterm birth complications as the leading causes of YLL. 15 provinces had cerebrovascular disease as the leading cause, and 2 had ischemic heart disease.

2. In 2013, cerebrovascular disease was the leading cause of YLL in 27 provinces, 5 had ischemic heart disease, and 1 had lung cancer. The most common non-communicable diseases, including ischemic heart disease, stroke, chronic obstructive pulmonary disease, and cancers of the liver, stomach, and lung were much more contributory to YLLs.

Evidence Rating Level: 2 (Good)

Study Rundown: This study examined trends for 240 causes of death for all 33 province-level administrative units in China from 1990-2013 by using the Global Burden of Disease Study (GBD) 2013 analysis. All available epidemiological and demographic data sources for China at the provincial level were systematically analyzed following the methods of the GBD Study 2013. Levels of and trends in all-cause mortality, years of life lost (YLL), and cause of death in all 33 provinces were assessed for years between 1990 and 2013. All provinces in China significantly improved life expectancy at birth between 1990-2013, though there is substantial difference in life expectancy between provinces. These differences are also present in cause of death structures between sexes and provinces. In all but 3 provinces, improvements in female life expectancy exceeded that of men. Reductions in infectious diseases have contributed toward improved life expectancy in most provinces, and non-communicable diseases were much more contributory to YLLs in 2013. Though this study is the first systematic analysis of provincial causes of death in China, it is limited by quantity and quality of data available in 1990, as data have become increasingly more available. The study results may be of value in better understanding the interactions between socio-economic development and public health.

The study was funded by China National Science & Technology Pillar Program 2013 (2013BAI04B02) and Bill & Melinda Gates Foundation.

Click to read the study, published today in The Lancet

RELATED REPORTS

2MM: Pharma Roundup – mRNA flu vaccine debuts, RAS inhibition extends pancreatic cancer survival, and new therapies advance for dermatomyositis and Tourette syndrome

2 Minute Medicine Rewind September 14, 2026

The 5x-multiplier algorithm reduces opioids prescribed at discharge

Relevant Reading: Global Burden of Disease, Injury and Risk Factor Study 2010: Its Policy Implications for China

In-Depth [retrospective cohort]: All provinces in China significantly improved life expectancy between 1990 and 2013. Such increases ranged from 4.0 years in Hebei province to 14.2 years in Tibet. In all but 3 provinces (Shanghai, Macao, and Hong Kong) improvements in female life expectancy exceeded those of men. The leading causes of YLL changed dramatically between 1990 and 2013. 16 of 33 provinces had lower respiratory infections or preterm birth complications as the leading causes of YLL. 15 provinces had cerebrovascular disease as the leading cause, and 2 had ischemic heart disease. In 2013, cerebrovascular disease was the leading cause of YLL in 27 provinces, five had ischemic heart disease, and one had lung cancer. In both men and women, reductions in diarrhea, lower respiratory infections, and other infections diseases have contributed toward improved life expectancy in most provinces. In 2013, the most common non-communicable diseases, including ischemic heart disease, stroke, chronic obstructive pulmonary disease, and cancers of the liver, stomach, and lung were much more contributory to YLLs.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Previous Post

2 Minute Medicine Rewind October 18 – October 25, 2015

Next Post

Early invasive strategy associated with reduced cardiac death after acute coronary syndrome

RelatedReports

2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Pharma Roundup

2MM: Pharma Roundup – mRNA flu vaccine debuts, RAS inhibition extends pancreatic cancer survival, and new therapies advance for dermatomyositis and Tourette syndrome

September 14, 2026
Weekly Rewinds

2 Minute Medicine Rewind September 14, 2026

September 14, 2026
Chronic Disease

The 5x-multiplier algorithm reduces opioids prescribed at discharge

September 13, 2026
Oncology

Historical redlining associated with lower breast cancer screening across urban neighborhoods

September 13, 2026
Next Post
Image-guided percutaneous drainage of pericardial effusions is safe and effective

Early invasive strategy associated with reduced cardiac death after acute coronary syndrome

UTI associated with increased risk of preeclampsia

Significant overtreatment of blood pressure and diabetes present amongst older diabetics

Successful regional implementation of pediatric chest pain algorithm

Majority of Chinese counties exceed under-5 mortality reduction of Millennium Development Goal 4

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2MM: Pharma Roundup – mRNA flu vaccine debuts, RAS inhibition extends pancreatic cancer survival, and new therapies advance for dermatomyositis and Tourette syndrome
  • 2 Minute Medicine Rewind September 14, 2026
  • The 5x-multiplier algorithm reduces opioids prescribed at discharge
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.